Citigroup
CEMI

Citigroup’s Chembio diagnostics, Inc. CEMI Stock Holding History

Citigroup’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,200
Closed -$1K – 6705
2022
Q2 		$1K Buy
+2,200
New +$1.46K ﹤0.01% 6177
2021
Q2 		– Sell
-1,339
Closed -$5K – 6638
2021
Q1 		$5K Sell
1,339
-2,338
-64% -$13K ﹤0.01% 5925
2020
Q4 		$17K Buy
3,677
+2,728
+287% +$14.1K ﹤0.01% 6760
2020
Q3 		$5K Sell
949
-1,565
-62% -$7.41K ﹤0.01% 7084
2020
Q2 		$8K Buy
+2,514
New +$23.9K ﹤0.01% 7162
2013
Q4 		– Sell
-3,571
Closed -$13K – 7477
2013
Q3 		$13K Buy
+3,571
New +$15.1K ﹤0.01% 6130

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Citigroup's CEMI Position: Q3 2022 in Review

Citigroup sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2022, closing a stake of 2,200 shares — an estimated $1K sold.

Citigroup first reported a position in CEMI in Q3 2013 and held it in 6 quarters. The position peaked at $17K in Q4 2020. 38 funds tracked by Wall St. Rank hold CEMI as of Q3 2022.

  • Citigroup reported no remaining Chembio diagnostics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 2,200 Chembio diagnostics, Inc. shares in Q3 2022, an estimated $1K.
  • Citigroup first reported a position in Chembio diagnostics, Inc. in Q3 2013 and held it in 6 quarters.
  • Citigroup's Chembio diagnostics, Inc. position peaked at $17K in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.